• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 VEGF 治疗后新生血管性年龄相关性黄斑变性黄斑裂孔再开放。

REOPENING OF MACULAR HOLE AFTER INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

机构信息

Department of Ophthalmology, McGill University Health Centre, Montreal, Québec, Canada.

出版信息

Retin Cases Brief Rep. 2020 Summer;14(3):255-259. doi: 10.1097/ICB.0000000000000688.

DOI:10.1097/ICB.0000000000000688
PMID:29252912
Abstract

PURPOSE

To describe the clinical course and surgical outcome of a patient with full-thickness macular hole recurrence after aflibercept injections for wet age-related macular degeneration.

METHODS

Case report with spectral domain optical coherence tomography retinal imaging.

RESULTS

An 84-year-old patient, with a successfully closed full-thickness macular hole by vitrectomy and internal limiting membrane (ILM) peel 4 years ago in the right eye, developed neovascular age-related macular degeneration (AMD) of the same eye. After 6 intravitreal aflibercept injections, visual acuity was 20/50, with minimal subretinal fluid (SRF). Four days after the seventh aflibercept injection, visual acuity decreased to 20/200. Spectral domain optical coherence tomography demonstrated a reopened full-thickness macular hole of diameter 430 μm, associated with a reduction in pigment epithelial detachment height, increase in SRF, and an epiretinal membrane (ERM). A 23-gauge pars plana vitrectomy with indocyanine green-assisted removal of residual ILM and ERM, and sulfur hexafluoride (SF6) 20% tamponade was performed. At 1 month postoperatively, the full-thickness macular hole was successfully closed and visual acuity improved to 20/80.

CONCLUSION

In wet AMD eyes with previously closed macular holes, hole reopening may occur as a rare complication of aflibercept therapy.

摘要

目的

描述一位湿性年龄相关性黄斑变性患者在接受阿柏西普注射治疗后全层黄斑裂孔复发的临床病程和手术结果。

方法

病例报告并结合频域光相干断层扫描视网膜成像。

结果

一位 84 岁的患者,右眼曾于 4 年前接受玻璃体切除术和内界膜(ILM)剥除术成功封闭全层黄斑裂孔,现同一眼发生新生血管性年龄相关性黄斑变性(AMD)。在接受 6 次玻璃体内阿柏西普注射后,视力为 20/50,仅有少量视网膜下液(SRF)。在第 7 次阿柏西普注射后 4 天,视力下降至 20/200。频域光相干断层扫描显示直径为 430μm 的全层黄斑裂孔重新开放,伴有色素上皮脱离高度降低、SRF 增加和视网膜内膜(ERM)。行 23G 经睫状体平坦部玻璃体切除术,并用吲哚青绿辅助去除残余 ILM 和 ERM,并进行 20%六氟化硫(SF6)眼内填充。术后 1 个月,全层黄斑裂孔成功闭合,视力提高至 20/80。

结论

在先前已封闭黄斑裂孔的湿性 AMD 眼中,裂孔再开放可能是阿柏西普治疗的罕见并发症。

相似文献

1
REOPENING OF MACULAR HOLE AFTER INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.抗 VEGF 治疗后新生血管性年龄相关性黄斑变性黄斑裂孔再开放。
Retin Cases Brief Rep. 2020 Summer;14(3):255-259. doi: 10.1097/ICB.0000000000000688.
2
Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.评估从玻璃体内注射雷珠单抗转换为阿柏西普治疗渗出性年龄相关性黄斑变性的眼中视网膜外层管状结构。
Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):61-67. doi: 10.1007/s00417-016-3423-x. Epub 2016 Jul 11.
3
A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗、雷珠单抗或阿柏西普治疗新生血管性年龄相关性黄斑变性的疗效比较。
Int Ophthalmol. 2017 Oct;37(5):1205-1214. doi: 10.1007/s10792-016-0391-4. Epub 2016 Nov 8.
4
SURGICAL MANAGEMENT OF FULL-THICKNESS MACULAR HOLE SUPERIMPOSED ON EXUDATIVE AGE-RELATED MACULAR DEGENERATION.全层黄斑孔合并渗出性年龄相关性黄斑变性的手术治疗。
Retin Cases Brief Rep. 2021 May 1;15(3):211-213. doi: 10.1097/ICB.0000000000000786.
5
Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy.经扁平部玻璃体切除术治疗的与年龄相关性黄斑变性相关的继发性黄斑裂孔的术中及荧光素血管造影结果。
BMC Ophthalmol. 2014 Sep 30;14:114. doi: 10.1186/1471-2415-14-114.
6
Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration.阿柏西普按需给药方案治疗持续性新生血管性年龄相关性黄斑变性的长期结果
Am J Ophthalmol. 2016 Jul;167:1-9. doi: 10.1016/j.ajo.2016.03.038. Epub 2016 Apr 2.
7
ASSESSMENT OF EARLY CHANGES IN SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AFTER INITIATION OF TREATMENT WITH INTRAVITREAL AFLIBERCEPT (EYLEA) OVER A 12-WEEK PERIOD FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Multicenter French Study (START).评估在 12 周的时间内接受玻璃体内阿柏西普(艾力雅)治疗的新生血管性年龄相关性黄斑变性患者的光谱域光相干断层扫描的早期变化:一项多中心法国研究(START)。
Retina. 2021 Mar 1;41(3):588-594. doi: 10.1097/IAE.0000000000002910.
8
Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.阿柏西普治疗抗血管内皮生长因子难治性新生血管性年龄相关性黄斑变性和息肉状脉络膜血管病变
Korean J Ophthalmol. 2015 Aug;29(4):226-32. doi: 10.3341/kjo.2015.29.4.226. Epub 2015 Jul 21.
9
Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration.玻璃体内注射雷珠单抗与阿柏西普治疗新生血管性年龄相关性黄斑变性的治疗并延长方案对比
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1671-1677. doi: 10.1007/s00417-019-04360-9. Epub 2019 May 29.
10
Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degeneration.抗VEGF疗法对年龄相关性黄斑变性中纤维血管性色素上皮脱离的疗效比较
Br J Ophthalmol. 2017 Jul;101(7):970-975. doi: 10.1136/bjophthalmol-2016-309434. Epub 2016 Dec 2.

引用本文的文献

1
Full-Thickness Macular Hole Caused by Acute Subretinal Hemorrhage From Wet Age-Related Macular Degeneration.湿性年龄相关性黄斑变性所致急性视网膜下出血引起的全层黄斑裂孔
J Vitreoretin Dis. 2023 Oct 18;8(1):82-85. doi: 10.1177/24741264231206281. eCollection 2024 Jan-Feb.
2
Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report.玻璃体腔注射康柏西普治疗变性近视继发脉络膜新生血管后黄斑裂孔性视网膜脱离:一例报告
BMC Ophthalmol. 2019 Jul 22;19(1):156. doi: 10.1186/s12886-019-1164-4.